REG - Goldman Sachs & Co. Mural Oncology PLC - Form 8.3 - MURAL ONCOLOGY PLC

Mural OncologyAnnouncement

01/05/2025 12:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250501:nRSA0866Ha&default-theme=true

RNS Number : 0866H  Goldman Sachs & Co. LLC  01 May 2025

 
FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER  RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

 Name of person dealing (Note 1)                                          GOLDMAN SACHS & CO. LLC
 Company dealt in                                                         MURAL ONCOLOGY PLC
 Class of relevant security to which the dealings being disclosed relate  USD 0.01 ordinary shares
 (Note2)
 Date of dealing                                                          30 April 2025

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in  (Note 3)

 

                                              Long             Short
                                              Number   (%)     Number   (%)
 (1) Relevant securities                      90,971   (0.52)  183,668  (1.06)
 (2) Derivatives (other than options)         89,372   (0.51)  0        (0.00)
 (3) Options and agreements to purchase/sell  0        (0.00)  0        (0.00)
 Total                                        180,343  (1.04)  183,668  (1.06)

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in  (Note 3)

 

 Class of relevant security:                  Long         Short
                                              Number  (%)  Number  (%)
 (1) Relevant securities
 (2) Derivatives (other than options)
 (3) Options and agreements to purchase/sell
 Total

 

3.    DEALINGS (Note 4)

(a) Purchases and sales

 

 Purchase/sale  Number of relevant securities  Price per unit  (Note 5)
 Sale           1                              2.6250 USD

 

(b) Derivatives transactions (other than options transactions)

 

 Product name, e.g. CFD  Nature of transaction  (Note 6)   Number of relevant securities  (Note 7)   Price per unit  (Note 5)

 

(c) Options transactions in respect of existing relevant securities

 

(i) Writing, selling, purchasing or varying

 

 Product name,e.g. call option  Writing, selling,  purchasing, varying etc.   Number of securities to which the option relates  (Note 7)   Exercise price  Type, e.g. American, European etc.  Expiry date  Option money paid/received per unit  (Note 5)

 

(ii)            Exercising

 

 Product name,e.g. call option  Number of securities  Exercise price per unit  (Note 5)

 

(d)            Other dealings (including transactions in respect of new securities)  (Note 4)

 

 Nature of transaction  (Note 8)   Details  Price per unit (if applicable)  (Note 5)

 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 Full details of any agreement, arrangement or understanding between the person
 disclosing and any other person relating to the voting rights of any relevant
 securities under any option referred to on this form or relating to the voting
 rights or future acquisition or disposal of any relevant securities to which
 any derivative referred to on this form is referenced.  If none, this should
 be stated.
 NONE

 

Is a Supplemental Form 8 attached? (Note 9)        YES

 

 Date of disclosure                                                01 May 2025
 Contact name                                                      Papa Lette and Andrzej Szyszka
 Telephone number                                                  +33(1) 4212 1459 / +48(22) 317 4817
 If a connected EFM, name of offeree/offeror with which connected
 If a connected EFM, state nature of connection (Note 10)

 

SUPPLEMENTAL FORM 8

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DETAILS OF OPEN POSITIONS
OPEN POSITIONS (Note 1)

 

 Product name,e.g. call option  Written or purchased  Number of relevant securities to which the option or derivative relates  Exercise price (Note 2)  Type, e.g. American, European etc.  Expiry date
 Swap                           Purchased             1                                                                        0.0000                   N/A                                 08/07/2025

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ITPUPUQUAUPAGGG